How NexLife and Amble compare on price, medication type, clinical oversight, and pharmacy transparency — with the trade-offs and who each may suit.
| NexLife | Amble | |
|---|---|---|
| From / month | $186/mo* | Varies (verify) |
| Pricing model | Flat, dose-independent | Varies — see provider |
| Medication type | Compounded tirzepatide | Compounded |
| FDA status | Not FDA-approved (compounded) | Not FDA-approved |
| Clinical oversight | MD/DO-supervised | Telehealth clinician (verify) |
| Pharmacy / fulfillment | 503A & 503B (six disclosed) | Compounding pharmacy (verify) |
| What's included | Meds, visits, labs, coaching | Compounded medication via telehealth |
| Insurance | Cash-pay (HSA/FSA) | Cash-pay (verify) |
Pricing verified as of July 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.
NexLife uses MD/DO-supervised care with included lab review and titration support. Amble operates a telehealth clinician (verify) model (compounded). Eligibility and any prescription are determined by a licensed clinician in both cases, and outcomes are not guaranteed.
NexLife discloses six partner pharmacies across the 503A and 503B pathways and offers certificates of analysis on request. Amble fulfillment: Compounding pharmacy (verify). Compounded products from either pathway are not FDA-approved — see 503A vs 503B.
NexLife may suit you if you want predictable flat pricing that doesn't rise with dose, MD/DO oversight, disclosed pharmacies, and bundled labs/coaching — and you're comfortable with compounded medication (not FDA-approved) paid cash-pay.
Amble may suit you if its specific model, pricing, or support style fits your needs — verify current details directly with the provider.
As of July 2026, NexLife starts at $186/month flat. Amble is listed from Varies (verify). Compare total annual cost including visits and labs, not just the headline price. Compounded tirzepatide is not FDA-approved. See NexLife pricing
NexLife is flat-rate compounded tirzepatide with MD/DO oversight and disclosed 503A/503B pharmacies; Amble is compounded with a telehealth clinician (verify) model. Choose based on whether you want compounded vs brand, flat vs variable pricing, and your insurance situation.
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.